These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34078824)

  • 1. Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy　- Insights From the J-MINUET Study.
    Hashimoto Y; Ozaki Y; Kan S; Nakao K; Kimura K; Ako J; Noguchi T; Suwa S; Fujimoto K; Dai K; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Wake M; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Yasuda S; Ismail TF; Muramatsu T; Izawa H; Takahashi H; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Circ J; 2021 Sep; 85(10):1710-1718. PubMed ID: 34078824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
    Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
    Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
    BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy.
    Mohebi R; Karimi Galougahi K; Garcia JJ; Horst J; Ben-Yehuda O; Radhakrishnan J; Chertow GM; Jeremias A; Cohen DJ; Cohen DJ; Maehara A; Mintz GS; Chen S; Redfors B; Leon MB; Stuckey TD; Rinaldi MJ; Weisz G; Witzenbichler B; Kirtane AJ; Mehran R; Dangas GD; Stone GW; Ali ZA
    JACC Cardiovasc Interv; 2022 Apr; 15(7):753-766. PubMed ID: 35305904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L; Zhang J; Huang Q; Cui R; Chen J
    BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
    Bharadwaj AS; Abu-Much A; Maini AS; Zhou Z; Li Y; Batchelor WB; Grines CL; Baron SJ; Redfors B; Lansky AJ; Basir MB; O'Neill WW
    Circ Cardiovasc Interv; 2024 Jul; 17(7):e013503. PubMed ID: 38708609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention - A five-year observational study.
    Wang HT; Chen YL; Wu CJ
    Int J Cardiol; 2016 Oct; 220():166-72. PubMed ID: 27379919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
    Shiraishi J; Kohno Y; Nakamura T; Yanagiuchi T; Hashimoto S; Ito D; Kimura M; Matsui A; Yokoi H; Arihara M; Hyogo M; Shima T; Sawada T; Matoba S; Yamada H; Matsumuro A; Shirayama T; Kitamura M; Furukawa K;
    Int Heart J; 2014; 55(4):301-6. PubMed ID: 24881584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.
    Tsai TT; Patel UD; Chang TI; Kennedy KF; Masoudi FA; Matheny ME; Kosiborod M; Amin AP; Messenger JC; Rumsfeld JS; Spertus JA
    JACC Cardiovasc Interv; 2014 Jan; 7(1):1-9. PubMed ID: 24456715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
    Chen H; Spirito A; Sartori S; Nicolas J; Cao D; Zhang Z; Baber U; Kamaleldin K; Guthrie J; Vogel B; Sweeny J; Krishnan P; Sharma SK; Kini A; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2023 Feb; 101(3):511-519. PubMed ID: 36691863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
    Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the atherothrombotic risk score for secondary prevention in patients with acute myocardial infarction: the J-MINUET study.
    Hashimoto T; Minami Y; Ako J; Nakao K; Ozaki Y; Kimura K; Noguchi T; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Hirata K; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Heart Vessels; 2021 Oct; 36(10):1506-1513. PubMed ID: 33880614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcomes of acute myocardial infarction in patients with chronic kidney disease.
    Smilowitz NR; Gupta N; Guo Y; Mauricio R; Bangalore S
    Int J Cardiol; 2017 Jan; 227():1-7. PubMed ID: 27846456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry.
    Bae EH; Lim SY; Cho KH; Choi JS; Kim CS; Park JW; Ma SK; Jeong MH; Kim SW
    Am J Kidney Dis; 2012 Jun; 59(6):795-802. PubMed ID: 22445708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
    Jones D; Spirito A; Sartori S; Smith KF; Pivato CA; Chiarito M; Cao D; Nicolas J; Beerkens F; Edens M; Pileggi B; Sen A; Zhang Z; Vogel B; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
    J Cardiol; 2023 Sep; 82(3):179-185. PubMed ID: 37187289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
    Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
    Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.